Plain-English translation of NCT05747937 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how ALS affects two parts of your nervous system: the autonomic nervous system (which controls things like heart rate and digestion) and the sensory nervous system (which processes touch and pain). By collecting skin biopsies and other tests from people newly diagnosed with ALS and comparing them to healthy volunteers, the study aims to find early warning signs that could help predict how quickly the disease will progress and how well treatments might work.
Currently, doctors don't have good ways to predict which ALS patients will progress quickly or slowly, or to measure whether new treatments are actually working. This study hopes to find biomarkers — measurable signals in the skin — that could help answer these questions and improve how we test new ALS therapies in the future.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have an initial visit where you'll undergo blood tests, genetic screening, a skin biopsy, neuropsychological testing, and questionnaires about your symptoms and quality of life. The researchers will also do special tests to check how your autonomic nervous system is working. You'll then come back for follow-up visits where they'll repeat some of the clinical exams and skin biopsies to see how things change over time. Your results will be compared with those from healthy volunteers matched to your age and sex.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy